We found that TMB showed differences related to the expression of LINC00987 in BRCA, BLCA, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), UCEC, uveal melanoma (UVM), thyroid carcinoma (THCA), stomach adenocarcinoma (STAD), SKCM, prostate adenocarcinoma (PRAD), pancreatic adenocarcinoma (PAAD), LUSC, LUAD, liver hepatocellular carcinoma (LIHC), brain lower-grade glioma (LGG), acute myeloid leukemia (LAML), KIRP, HNSC, esophageal carcinoma (ESCA), and lymphoid neoplasm diffuse large B-cell lymphoma (DLBC; Figure 10A). Here, LINC00987 is linked to prostate adenocarcinoma.